跳至主要内容
临床试验/IRCT20200925048836N3
IRCT20200925048836N3招募中2 期

comparing single dose and double dose of Gonadotropin-releasing hormone (GNRH ) agonist in endometriosis triggering undergoing assisted reproductive technology (ART) cyle

Shiraz University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
21 years 至 35 years(—)
性别
Female

入选标准

  • Women with a definite diagnosis of endometriosis based on pathology report
  • Aged between 21 and 35 years
  • The first period of using Assisted reproductive technology (ART) method
  • Normal serum Follicle stimulating hormone (FSH) concentration in primary follicular phase
  • Anti mullerian hormone (AMH) more than 0.5, presence of both ovary
  • Having the ART use indication that they are willing to participate in the study

排除标准

  • History of uterine and ovary surgery
  • Poly cystic ovarian syndrome
  • Triggering with Human chorionic gonadotropin (HCG) drug
  • Severe fertilizing disorder in spouse
  • Patient with hypo gonadotrpic hypogonadism and uterine abnormality

研究者

相似试验